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Zoo veterinarians deal with animal species wherein each single treatment event may imply 
logistic challenges and health hazards for the animals (e.g., remote injection, immobilization). 
Long-acting antibiotics meet the need of providing antibiotic cover in species that are difficult to 
medicate on a regular basis. For domestic animals, new long-acting antibiotics were developed 
recently, but the question is what can be used in zoological and wildlife medicine?  
 
With cefovecin, the very long half-life in dogs and cats allows a dosing interval of 14 days.
14,15
 
However, species differences in pharmacokinetics are highly relevant and likely preclude the use 
of this antimicrobial agent in non-evaluated species.
17
 For cattle, pigs, and horses, a sustained 
release ceftiofur suspension (ceftiofur crystalline free acid, CCFA,) was developed. 
Pharmacokinetic studies are underway for other species. In reptiles, other cephalosporins allow a 
long dosing interval (e.g., ceftazidime).
13
 Tulathromycin is a long-acting macrolid antibiotic used 
in domestic animals with the potential of evaluation for zoo animals. Long-acting tetracyclines, 
and doxycyline formulations have been utilized in practice for a longer time. Other modes of 
administration may be employed so that antibiotics are administered at a less frequent interval 
(e.g., ballistic implants, impregnated beads).  
 
In Table 1 we compile a list of long-acting antibiotics that may be useful for the zoo veterinarian. 
Examples of pharmacokinetic data of several long-acting antibiotics are included, as well as, 
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Table 1. Examples of pharmacokinetic data of long-acting antibiotics for different species. 
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